Fund Holdings — General Catalyst Group Management, LLC

Total Portfolio Value
$188.52M
Total Bought
$60.94M
Total Sold
$84.96M
Net Transaction
-$24.02M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Parabilis Medicines, Inc.01,600,937+1,600,937043,81823.24%+43,818
ArriVent BioPharma, Inc.(AVBP)1,494,7861,494,786034,48551,92927.55%+17,444
Odyssey Therapeutics, Inc.0810,272+810,272015,1608.04%+15,160
Maplebear, Inc.(CART)710,711710,711026,62333,65217.85%+7,029
Fractyl Health, Inc.(GUTS)4,884,1934,884,186-72,2363,8802.06%+1,644
Eikon Therapeutics, Inc.(EIKN)305,233305,23303,2293,9832.11%+754
Doordash Inc.(DASH)02,850+2,85005260.28%+526
Ethos Technologies, Inc.(LIFE)74,17974,17908291,3460.71%+517
Carvana Co(CVNA)06,465+6,46504260.23%+426
Amazon.com Inc.(AMZN)2,5823,882+1,3005389250.49%+387
Meta Platforms Inc.(META)6581,320+6623767440.39%+367
Coupang Inc.(CPNG)36,67754,677+18,0006929500.50%+257
Maze Therapeutics, Inc.(MAZE)1,035,9101,035,910030,92230,91216.40%-10
Figma, Inc.(FIG)14,84514,84503142690.14%-45
GITLAB INC(GTLB)921,4050-921,40519,9390—-19,939
SAMSARA INC(IOT)2,000,0000-2,000,00063,3800—-63,380
Page 1 of 1